EP
AMGN icon

Elkhorn Partners’s Amgen AMGN Stock Holding History

Elkhorn Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-130
Closed -$36.7K – 51
2025
Q3 		$36.7K Buy
+130
New +$37.7K 0.02% 33
2021
Q3 		– Sell
-200
Closed -$49K – 42
2021
Q2 		$49K Buy
200
+150
+300% +$36.9K 0.03% 31
2021
Q1 		$12K Buy
+50
New +$11.9K 0.01% 41

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Elkhorn Partners's AMGN Position: Q4 2025 in Review

Elkhorn Partners sold out of Amgen (AMGN) in Q4 2025, closing a stake of 130 shares — an estimated $36.7K sold.

Elkhorn Partners first reported a position in AMGN in Q1 2021 and held it in 3 quarters. The position peaked at $49K in Q2 2021. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Elkhorn Partners reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Elkhorn Partners sold 130 Amgen shares in Q4 2025, an estimated $36.7K.
  • Elkhorn Partners first reported a position in Amgen in Q1 2021 and held it in 3 quarters.
  • Elkhorn Partners's Amgen position peaked at $49K in Q2 2021.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Elkhorn Partners's 13F filing for Q4 2025, filed 17 Feb 2026.